Uncategorized

Find the Money Before the Patent Dies: How to Identify Out-Licensing Targets Near Drug Patent Expiry — and Capture Value That Most Companies Leave on the Table

Unlocking Hidden Value in Pharma: How to Identify Out-Licensing Opportunities Before Patent Expiry
In the fiercely competitive world of pharmaceuticals, timing is everything. As patent protections near expiration, many companies scramble to maximize th…

Find the Money Before the Patent Dies: How to Identify Out-Licensing Targets Near Drug Patent Expiry — and Capture Value That Most Companies Leave on the Table Read Post »

Uncategorized

Know Before You File: Using Patent Landscape Analysis to Drive Go/No-Go Decisions in Generic and Biosimilar Drug Development

In the fiercely competitive world of pharmaceuticals, the difference between a blockbuster success and a costly misstep often hinges on one critical decision: whether to proceed with a new drug development project. Yet, many companies still rely on tra…

Know Before You File: Using Patent Landscape Analysis to Drive Go/No-Go Decisions in Generic and Biosimilar Drug Development Read Post »

Uncategorized

Own the Clock: How Pharma Companies Extract Maximum Value from Patent Term Extensions and Secondary Patents

In the fiercely competitive world of pharmaceuticals, every second counts. As drug developers race to bring innovative therapies to market, the clock isn’t just ticking—it’s being strategically managed, extended, and optimized to maximize revenue. But …

Own the Clock: How Pharma Companies Extract Maximum Value from Patent Term Extensions and Secondary Patents Read Post »

Biotechblog
Scroll to Top